Interchim has announced the acquisition of the flash chromatography branch of Armen Instrument, a French manufacturer of scientific instruments.
Interchim has announced the acquisition of the flash chromatography branch of Armen Instrument, a French manufacturer of scientific instruments.
“The acquisition will enable Interchim to provide a tailored and effective response to the productivity concerns of industry and research units as regards purifying potential new medicines, and synthetic molecules and biomolecules,” said Lionel Boch, Président du Directoire d'Interchim, in a statement. “Furthermore, this acquisition will guarantee even greater reliability and ensure the future of the puriFlash and Spot Flash products.”
According to the company this acquisition is a boost to the concept of Ultra Performance Flash Purification initiated by Interchim in France and internationally over recent years. The company reports that the acquisition will enable it to offer an appropriate and efficient solution to the productivity requirements in industry and research centres for the purification of new drug candidates and synthesized molecules or biomolecules.
Armen Instrument specializes in liquid chromatography from the laboratory scale to industrial production. In a statement discussing the acquisition, Armen founder Francois Couillard said that “this sale will enable Armen Instrument to focus on its core businesses of developing and marketing preparative high-performance chromatography machines with modular and integrated systems, as well as Centrifuge Partition Chromatography and CPC/CCC solutions.
For more on both companies visit them on-line at www.interchim.com and www.armen-instrument.com
A Dream Come True: Separation Science at Analytica
November 6th 2024At Analytica this year, an oral session titled “A Dream Comes True: Fantastic News from Analytical Chemistry” focused on cutting-edge techniques in separation science in Hall 5 of the International Congress Center Munich (ICM) International Congress Center Munich (ICM).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.